- About Us
- Who We Serve
- Contact Us
MTF Biologics entered the breast reconstruction field because of surgeons like you. We had already established a reputation as an allograft innovator. Extending it into the Plastic Surgery arena, we listened—learning what common acellular dermal matrix (ADM) challenges you were dealing with. Since then, we’ve helped to develop breast reconstruction ADMs, nose reshaping grafts, soft tissue filling solutions and more—all designed to generate better surgical experiences and patient outcomes.
MTF Biologics breast reconstruction ADMs are the product of a deeper cut in the dermal tissue—procured from a cut below the dense collagen structure in the papillary dermis—which results in better handling and faster cell incorporation for enhanced healing.
Created exclusively for breast reconstruction in partnership with plastic surgeons nationwide, it’s the ADM you asked for:
Renuva is an off-the-shelf allograft adipose matrix engineered to treat small-volume aesthetic irregularities, the kind that detract from smooth contours and flawless skin, without the need for liposuction.
Renuva has numerous applications:
Science drives everything we do, from our research and development to our processing methods. And we prioritize clinically-based evidence. Explore our wide range of peer-reviewed, published studies outlining the safety of our tissue and excellent patient outcomes.
PSF/MTF Allograft Tissue Research Grant Program supports applied research using allograft technologies in plastic and reconstructive surgery; Applications for 2018 program now open.Read more »